08:06 AM EDT, 03/16/2026 (MT Newswires) -- P. Kent Hawryluk, Director, President and Chief Executive Officer, on March 13, 2026, executed a purchase for 18,500 shares in Mbx Biosciences ( MBX ) for $525,663. Following the Form 4 filing with the SEC, Hawryluk has control over a total of 1,215,051 common shares of the company, with 728,274 shares held directly and 486,777 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1776111/000119312526107268/xslF345X05/ownership.xml